New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 19, 2018 - Osmotica Pharmaceutical announced the FDA approval of Osmolex ER (amantadine), for the treatment of Parkinson's disease and for the treatment of drug-induced extrapyramidal reactions in adult patients.
Download PDF
Return to publications
